Global Rise of Compounded Weight-Loss Medicines: A Worrisome Trend

The rise of compounded weight-loss drugs has emerged as a pressing global health issue, threatening consumers and health-care systems. Factors fueling this crisis include the desire for rapid weight-loss options, inadequate regulatory frameworks, and the easy availability of compounded products through online platforms and social media. Vulnerable populations, particularly those searching for low-cost treatments, are hit hardest. Tackling this escalating problem calls for a comprehensive strategy: enhancing regulatory oversight, raising public awareness, and fostering stakeholder collaboration. We can reduce the health dangers of compounded weight-loss medications by addressing the underlying causes and improving consumer safety. This article examines the risks associated with compounded weight-loss drugs and suggests practical measures to protect public health.

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-06-07
DOI
https://doi.org/10.1210/jendso/bvaf084
Citations
1
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global Rise of Compounded Weight-Loss Medicines: A Worrisome Trend

Rohini Garg, Nikhil Sood
1 citations
Journal of the Endocrine Society
Pharmacology and Obesity Treatment
1.39
article

Global Rise of Compounded Weight-Loss Medicines: A Worrisome Trend

Rohini Garg, Nikhil Sood
article en
1 citations

Abstract

The rise of compounded weight-loss drugs has emerged as a pressing global health issue, threatening consumers and health-care systems. Factors fueling this crisis include the desire for rapid weight-loss options, inadequate regulatory frameworks, and the easy availability of compounded products through online platforms and social media. Vulnerable populations, particularly those searching for low-cost treatments, are hit hardest. Tackling this escalating problem calls for a comprehensive strategy: enhancing regulatory oversight, raising public awareness, and fostering stakeholder collaboration. We can reduce the health dangers of compounded weight-loss medications by addressing the underlying causes and improving consumer safety. This article examines the risks associated with compounded weight-loss drugs and suggests practical measures to protect public health.

Journal of the Endocrine SocietyVol. 9(8)
Banner Health (US), CHI Health Mercy Council Bluffs (US)
Openalex Percentile: Top 20%
Pharmacology and Obesity Treatment
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Global Rise of Compounded Weight-Loss Medicines: A Worrisome Trend — Rohini Garg, Nikhil Sood · Journal of the Endocrine Society (2025) | TGRS Research Map | TGRS